Tiapride Hydrochloride

盐酸硫必利

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTiapride Hydrochloride
Drug Alias Nametiapridum盐酸泰必利泰必利盐酸盐tiapridetiaprida +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsTic DisordersDyskinesiasBrain Infarction +[5] 
Global Approved IndicationsDyskinesiasBrain InfarctionParkinson Disease
Approved Indications in ChinaDyskinesiasParkinson Disease
Original Approved Country/TerritoryN/A
Original Approved Date1974/06/01
Country/TerritoryBelgiumGermanyFrance +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Tasly Diyi Pharmaceutical Co Ltd
Inactive CompaniesTasly Pharmaceuticals Inc
Active IndicationsDyskinesiasBrain InfarctionParkinson Disease
Inactive IndicationsTic DisordersTourette Syndrome

Other Information

ATC CodeN05AL03
Related LinksWikipediaKEGG